Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study.

Zhewu WangZachary D ZuschlagUrsula S MyersMark Hamner

Published in: Depression and anxiety (2022)

In Veterans with ADHD comorbid with PTSD, atomoxetine demonstrated modest efficacy for ADHD symptoms; quality of life measures and PTSD symptoms were not affected.

Keyphrases

attention deficit hyperactivity disorder
posttraumatic stress disorder
autism spectrum disorder
social support
working memory
placebo controlled
study protocol
sleep quality
double blind
depressive symptoms
clinical trial
physical activity
locally advanced